These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30337289)

  • 1. Development of acquired haemophilia A in a patient treated with alemtuzumab for multiple sclerosis.
    Madeley J; Hodges G; Birchley A
    BMJ Case Rep; 2018 Oct; 2018():. PubMed ID: 30337289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosis.
    McCaughan G; Massey J; Sutton I; Curnow J
    BMJ Case Rep; 2017 Dec; 2017():. PubMed ID: 29212866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired haemophilia A as a secondary autoimmune disease after alemtuzumab treatment in multiple sclerosis: A case report.
    Pisa M; Della Valle P; Coluccia A; Martinelli V; Comi G; D'Angelo A; Moiola L
    Mult Scler Relat Disord; 2019 Jan; 27():403-405. PubMed ID: 30513503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired haemophilia A after alemtuzumab treatment of multiple sclerosis.
    Brink HS; Moll W; Sandberg Y
    Br J Haematol; 2020 Jul; 190(1):13. PubMed ID: 32301108
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune thyroid disease following treatment with alemtuzumab for multiple sclerosis.
    Alamo A; Condorelli RA; La Vignera S; Calogero AE
    Int J Immunopathol Pharmacol; 2019; 33():2058738419843690. PubMed ID: 30968726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of an anti-infective screening and monitoring protocol together with infectious disease consultation in preventing infective adverse events in patients treated with anti-CD20/CD52 agents for multiple sclerosis.
    Zappulo E; Buonomo AR; Moccia M; Pinchera B; Villari R; Petracca M; Lanzillo R; Scotto R; Carotenuto A; Viceconte G; Schiano Moriello N; Bruno L; Gentile I; Brescia Morra V
    Mult Scler Relat Disord; 2022 Jul; 63():103814. PubMed ID: 35487032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report.
    Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M
    Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alemtuzumab-induced red cell aplasia and other immune cytopenias: not so 'pure'.
    Aitken L; Patel R; D'Rozario J; Choi P
    Immunotherapy; 2022 Feb; 14(2):95-99. PubMed ID: 34743591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired hemophilia A and other autoimmune diseases after alemtuzumab therapy for multiple sclerosis: A report of two cases.
    Comini-Frota ER; Campos APF; Neto APG; Christo PP
    Mult Scler Relat Disord; 2020 Sep; 44():102181. PubMed ID: 32531751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful steroid pulse treatment in childhood acquired haemophilia with nephrotic syndrome.
    Sakai M; Shima M; Shirahata A
    Haemophilia; 2005 May; 11(3):285-9. PubMed ID: 15876276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early neutropenia with thrombocytopenia following alemtuzumab treatment for multiple sclerosis: case report and review of literature.
    Maniscalco GT; Cerillo I; Servillo G; Napolitano M; Guarcello G; Abate V; Improta G; Florio C
    Clin Neurol Neurosurg; 2018 Dec; 175():134-136. PubMed ID: 30419425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired haemophilia A after alemtuzumab therapy.
    van der Zwan M; Leebeek FWG; Sandberg Y; Kruip MJHA; Hesselink DA
    Haemophilia; 2020 Nov; 26(6):e337-e339. PubMed ID: 32700327
    [No Abstract]   [Full Text] [Related]  

  • 13. Spinal epidural haematoma in haemophilia A with inhibitors--efficacy of recombinant factor VIIa concentrate.
    Leach M; Makris M; Hampton KK; Preston FE
    Haemophilia; 1999 May; 5(3):209-12. PubMed ID: 10444290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment.
    Barone S; Scannapieco S; Torti C; Filippelli E; Pisani V; Granata A; Console D; Demonte G; Tallarico T; Polidoro S; Quattrone A; Valentino P
    Mult Scler Relat Disord; 2018 Feb; 20():6-8. PubMed ID: 29272733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alemtuzumab as rescue therapy in case of multiple sclerosis rebound following Natalizumab break: Clinical case and literature review.
    Federle L; Puthenparampil M; Stenta G; Paolo G; Francesco P
    Mult Scler Relat Disord; 2019 May; 30():262-264. PubMed ID: 30851640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired Hemophilia A Presenting as Intramuscular Hematoma.
    Al-Shbool G; Vakiti A
    J Investig Med High Impact Case Rep; 2018; 6():2324709618817572. PubMed ID: 30574513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First report of real-time monitoring of coagulation function potential and IgG subtype of anti-FVIII autoantibodies in a child with acquired hemophilia A associated with streptococcal infection and amoxicillin.
    Takeyama M; Nogami K; Kajimoto T; Ogiwara K; Matsumoto T; Shima M
    Int J Hematol; 2018 Jan; 107(1):112-116. PubMed ID: 28597369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe aquired haemophilia A treated with recombinant factor VIIa.
    Shafi T; Jeha MT; Black L; Al Douri M
    Br J Haematol; 1997 Sep; 98(4):910-2. PubMed ID: 9326188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune reconstitution after alemtuzumab therapy for multiple sclerosis triggering Graves' orbitopathy: a case series.
    Roos JCP; Moran C; Chatterjee VK; Jones J; Coles A; Murthy R
    Eye (Lond); 2019 Feb; 33(2):223-229. PubMed ID: 30498266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT.
    Cipolla G; Relo R; Pasciuta E; Catalano D; Lo Bello F; Coppolino I; Ruggeri P; Proietto A; Buccafusca M; Cutroneo PM; Trifirò G; Caramori G
    Monaldi Arch Chest Dis; 2020 Jul; 90(3):. PubMed ID: 32702962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.